Asian Spectator


The Times

.

LANDMARK’s ‘Destination CENTRAL’ Opens an Inspiring New Chapter for the Festive Season in Hong Kong

Heightening the Global Momentum of Louis Vuitton’s Monumental Façade and Welcoming the Arrival of “Christmas at The Gloucester Hotel”HONG KONG SAR – Media OutReach News...

Defying the Market with Over 50% Growth | A-Share Listed Building Materials Giant HUAFULI Enters Hong Kong

With 30 Years of Industry Dedication, A-Share Listed Enterprise Huali Shares Achieves Over 50% Growth Against Market TrendsHUAFULI Makes Its First Foray into Hong Kong with the Grand Opening...

Hyundai NEXO Fuel Cell Electric Vehicle fleet arrives in Austr...

SYDNEY, June 18, 2020 /PRNewswire-AsiaNet/ -- - 20 zero-emissions NEXO hydrogen powered vehicles have landed in Australia, ready to be deployed into the ACT Government fleet - Australia's fi...

Top Energy Leaders to discuss "Transforming Energy: Invest, In...

SINGAPORE, Sept. 26, 2018/PRNewswire-AsiaNet/-- The 11th Singapore International Energy Week (SIEW) will bring together distinguished global energy leaders to share insights and perspectives...

30th Hong Kong Book Fair opens next month

Benjamin Chau, HKTDC Deputy Executive Director, said the Hong Kong Book Fair Cultural Events Advisory Panel has selected Sci-Fi and Mystery as the theme for the 2019 HKTDC Hong Kong Book Fai...

Mindray Transforms Spot Check Patient Monitoring with New VS S...

SHENZHEN, China, Jan. 26, 2021 /PRNewswire-AsiaNet/ -- Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, today launched its new VS 9 and VS 8 Vi...

NordVPN Study: YouTube has the most desired restricted content

LONDON, March 4, 2021 /PRNewswire-AsiaNet/ -- Research explores what type of online service the Japan wants to access the most and whyThe things people search for on engines like Google can ...

Antai College of Economics and Management ranked 11th in the F...

SHANGHAI, Nov. 19, 2019 /PRNewswire-AsiaNet/ -- On November 18, 2019, the Financial Times (hereinafter referred to as FT) announced the Top 100 EMBA Program 2019. The EMBA program of Antai C...

Pianoland announces its second outlet at Westgate, Singapore

Bringing Quality Music to the Heartlands with Grand Opening at Westgate, Singapore SINGAPORE - Media OutReach Newswire - 30 April 2024 - Pianoland, a destination for piano players, is thril...

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

SYDNEY, Apr 8, 2020 - (ACN Newswire) - Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations.

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

View and Download the COVID-19 Australia Data Bulletin here. https://novotech-cro.com/covid-19-notice

The data is part of a new series prepared for Novotech clients detailing the current status of trials in the Asia-Pacific during the global COVID-19 crisis.

Novotech CEO Dr John Moller said the Bulletin series taps local knowledge of fundamentals in the sector and shows which countries in the region are able to support clinical research for Novotech and its clients during this time.

"While the situation is always evolving, Australia appears to be managing the crisis well. Our sites have changed how they manage trials in line with Australian Government health guidelines and most are still able to deliver the clinical trial services we need for our clients," said Dr Moller. "Study delays caused by COVID-19 can be rapidly addressed by activating new sites in Australia and Asia."

Australia has attractive start-up times, world leading investigators and research teams, and valuable rebates of up to 43.5% on clinical trial spend.

About Novotech

Novotech, established in 1996, is internationally recognized as the leading full-service contract research organization (CRO) in Asia-Pacific. Novotech provides clinical development services across all clinical trial phases and therapeutic areas and has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotech companies.

Novotech obtained the ISO 27001, the best-known standard in the ISO family, providing the requirements for an Information Security Management System. Together with the ISO 9001 Quality Management system, Novotech aims at the highest IT security and quality standards for patients and biotechnology companies. Visit http://novotech-cro.com.

For RFP enquiries: Please fill out the form available at https://novotech-cro.com/talk-to-an-expert

Media ContactSusan Fitzpatrick-Napiercommunications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girişStreamEastCrackStreamscialis 20 mg fiyathttps://elektroniksigarakeyfi.net/marka/voopoo/taraftarium24taraftarium24taraftarium24